Bioject

Tigard, United States Founded: 1985 • Age: 41 yrs Acquired By Inovio Pharmaceuticals
Needle-free injection therapies are developed for medical drug delivery.
Request Access

About Bioject

Bioject is a company based in Tigard (United States) founded in 1985 was acquired by Inovio Pharmaceuticals in March 2016.. Bioject operates in a competitive market with competitors including Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others.

  • Headquarter Tigard, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioject Medical Technologies Inc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $994.55 K (USD), Post-IPO

    Jan 24, 2013

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Bioject

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $994,550
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2013 Amount Post-IPO - Bioject Valuation

investors

Dec, 2009 Amount Post-IPO - Bioject Valuation

investors

Sep, 2007 Amount Post-IPO - Bioject Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Bioject

Bioject has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Inovio Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Developer of vaccines for the treatment of cancer and infectious diseases
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Bioject

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Bioject

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioject Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bioject

Bioject operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drug delivery solutions via single-walled carbon nanotubes are offered.
domain founded_year HQ Location
Drug delivery platforms and therapeutics for ophthalmology are developed.
domain founded_year HQ Location
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
domain founded_year HQ Location
Erythrocyte encapsulation systems for drug delivery are developed.
domain founded_year HQ Location
Provider of needle-free injection technology
domain founded_year HQ Location
Provider of a proprietary platform for gene therapy
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioject

Frequently Asked Questions about Bioject

When was Bioject founded?

Bioject was founded in 1985 and raised its 1st funding round 20 years after it was founded.

Where is Bioject located?

Bioject is headquartered in Tigard, United States. It is registered at Tigard, Oregon, United States.

What does Bioject do?

Bioject Medical Technologies develops needle-free injection therapies (NFITS). The companys technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. The company claims that this creates an ultra-fine stream of fluid that penetrates the skin and delivers medication in a fraction of a second. Products include: Bioject 2000 Needle Free Injection System (to deliver intramuscular injections); ZetaJet (for subcutaneous or intramuscular injections); Drug Reconstitution System (connector to withdraw medication from a vial without using a needle); and Free Vial Adapter (plastic device to replaces a fill needle).

Who are the top competitors of Bioject?

Bioject's top competitors include Oxular, PharmaJet and Splice Bio.

Who are Bioject's investors?

Bioject has 1 investor. Key investors include Inovio Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available